# INcrease Of VAgal TonE in CHF

> **NCT01303718** · PHASE3 · TERMINATED · sponsor: **BioControl Medical** · enrollment: 730 (actual)

## Conditions studied

- Left Ventricular Dysfunction
- Heart Failure

## Interventions

- **DEVICE:** CardioFit® System
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT01303718
- **Lead sponsor:** BioControl Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-02
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 730 (ACTUAL)
- **Why stopped:** Futility of Primary Efficacy Endpoint
- **Last updated:** 2015-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01303718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01303718, "INcrease Of VAgal TonE in CHF". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01303718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*